Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both von Koschmieder, S, Mughal, T I, Hasselbalch, H C, Barosi, G, Valent, P, Kiladjian, J-J, Jeryczynski, G, Gisslinger, H, Jutzi, J S, Pahl, H L, Hehlmann, R, Maria Vannucchi, A, Cervantes, F, Silver, R T, Barbui, T

Volltext

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study von Tefferi, A, Rumi, E, Finazzi, G, Gisslinger, H, Vannucchi, A M, Rodeghiero, F, Randi, M L, Vaidya, R, Cazzola, M, Rambaldi, A, Gisslinger, B, Pieri, L, Ruggeri, M, Bertozzi, I, Sulai, N H, Casetti, I, Carobbio, A, Jeryczynski, G, Larson, D R, Müllauer, L, Pardanani, A, Thiele, J, Passamonti, F, Barbui, T

Volltext

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria von Gisslinger, H, Jeryczynski, G, Gisslinger, B, Wölfler, A, Burgstaller, S, Buxhofer-Ausch, V, Schalling, M, Krauth, M-T, Schiefer, A-I, Kornauth, C, Simonitsch-Klupp, I, Beham-Schmid, C, Müllauer, L, Thiele, J

Volltext

Response to Harrison et al. ‘Clinically relevant differences between BCSH and WHO diagnostic criteria for ET’ von Gisslinger, H, Jeryczynski, G, Wölfler, A, Beham-Schmid, C, Thiele, J

Volltext

First-line daratumumab shows high efficacy and tolerability even in advanced AL amyloidosis: the real-world experience von Jeryczynski, G., Antlanger, M., Duca, F., Binder-Rodriguez, C., Reiter, T., Simonitsch-Klupp, I., Bonderman, D., Kain, R., Krauth, M.-T., Agis, H.

Volltext

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria von Gisslinger, H, Jeryczynski, G, Gisslinger, B, Wölfler, A, Burgstaller, S, Buxhofer-Ausch, V, Schalling, M, Krauth, M-T, Schiefer, A-I, Kornauth, C, Simonitsch-Klupp, I, Beham-Schmid, C, Müllauer, L, Thiele, J

Volltext

1895P Higher modified Glasgow Prognostic Score in cancer patients at the Emergency Department is associated with an increased risk of hospital admissions von Huber, D.F-X., Pasalic, S., Starzer, A.M., Berger, J.M., Englisch, C., Kleinberger, M., Jeryczynski, G., Mair, M., Fuereder, T., Bartsch, R., Berghoff, A.S., Preusser, M., Minichsdorfer, C.

Volltext

Response to Harrison et al. 'Clinically relevant differences between BCSH and WHO diagnostic criteria for ET%apos von Gisslinger, H, Jeryczynski, G, Wölfler, A, Beham-Schmid, C, Thiele, J

Volltext

Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria von Gisslinger, H, Jeryczynski, G, Gisslinger, B, Wölfler, A, Burgstaller, S, Buxhofer-Ausch, V, Schalling, M, Krauth, M-T, Schiefer, A-I, Kornauth, C, Simonitsch-Klupp, I, Beham-Schmid, C, Müllauer, L, Thiele, J

Volltext